Business
SpaceX's IPO and Business Trends
SpaceX completed its historic initial public offering (IPO), becoming the sixth most valuable U.S. company despite being a smaller revenue player compared to tech giants. Meanwhile, drugmakers are competing for a share in the obesity drugs market.
Coverage timeline — 3 articles
CNBC
After its Nasdaq debut on Friday, SpaceX was the sixth most-valuable U.S. company, despite being a fraction the size by revenue of tech's megacaps.
2026-06-13 12:00 UTC
CNBC
Drugmakers are betting they can crack into the obesity drug market that Novo Nordisk and Eli Lilly currently dominate.
2026-06-13 12:00 UTC
CNBC
Rivian CEO RJ Scaringe started a robotics company late last year called Mind Robotics that he says has has raised more than $1 billion.
2026-06-13 12:00 UTC